Oral medication is the leading choice for multiple sclerosis treatment: Study

The majority of individuals with multiple sclerosis (MS) treat the chronic and progressive neurological disorder with oral medications, likely because of many factors, including convenience, consumer advertising and approval by health insurers, according to Rutgers researchers.

Leave A Comment

Your email address will not be published. Required fields are marked *